Journal of Medicinal Chemistry p. 750 - 757 (1993)
Update date:2022-08-17
Topics:
Kawasaki
Knapp
Kramer
Walton
Wire
Hashimoto
Yamamura
Porreca
Burks
Hruby
We have designed and synthesized several cyclic disulfide-containing peptide analogs of dynorphin A (Dyn A) which are conformationally constrained in the putative 'address' segment of the opioid ligand. Several of these Dyn A analogs exhibit unexpected apparent selectivities for the κ and μ opioid receptors(s) of the central vs peripheral nervous systems. Thus, incorporation of conformational constraint in the putative 'address' segment of Dyn A analogs has resulted in the κ/μ opioid receptor ligands [L- Pen5,Cys11]Dyn A1-11-NH2 (4), [Cys5,Cys10]Dyn A1-11-NH2 (5), [Cys5,Cys9]Dyn A1-11-NH2 (6), and [Cys4,Cys9,Arg10]Dyn A1-11- NH2 (7). All of these analogs possess high κ and μ opioid receptor affinities for the central receptor (guinea pig brain), but effect only weak potency at peripheral κ and μ opioid receptors (GPI). In fact cyclic dynorphin A analog 4 shows >19 000-fold differences between central κ opioid affinity and potency in the guinea pig ileum (GPI). Additionally analog 4 is not an antagonist in the GPI, suggesting possible receptor differences between these sites. Substitution of Tyr1 by Phe1 in the cyclic 1-11 series gave the analog [Phe1,Cys5,Cys11]Dyn A1-11-NH2 (1) that was surprisingly potent in the guinea pig brain binding assay (IC50 = 15.1 nM) at the κ receptor, but was inactive in the GPI and mouse vas deferens bioassays. D-Ala2 and Tic4 analogs of 1 had lower affinity at brain κ receptors and had very weak potencies in the GPI and MVD bioassays. On the other hand, [Cys6,Cys10]Dyn A1-11-NH2 (8), [Cys8,D-Cys13]Dyn A1- 13-NH2 (9), [D-Cys8,D-Cys12]Dyn A1-13-NH2 (10), and [D- Pro10,Cys5,Cys13]Dyn A1-13-NH2 (11) were surprisingly potent in the GPI bioassay, though considerable apparent selectivity for central receptors is still retained. The apparent lack of correlation between the pharmacological profiles observed in smooth muscle and in the brain binding assays, particularly with 1 and 4, may suggest the existence of different subtypes of the κ and μ opioid receptors in the brain and peripheral systems.
View MoreZibo Linzi Darong Fine Chemical Co., Ltd
Contact:86-532-67773200; 15689126900
Address:Qidu town,Linzi district,Zibo city,Shandong province,China
Changde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
JinTan Pingsheng Chemical Co.,Ltd
Contact:+86-519-82828200
Address:NO.11Danfengxilu Road,Jintan City,Jiangsu,China
Zibo Linzi Darong Fine Chemical Co., Ltd
Contact:86-532-67773200; 15689126900
Address:Qidu town,Linzi district,Zibo city,Shandong province,China
Oren Hydrocarbons (Qingdao) Co., Ltd.
Contact:+86-532-68607667-801
Address:Room 3 # 302, No.9 Qingyun Road, Qingdao, China
Doi:10.1016/j.tetlet.2007.04.023
(2007)Doi:10.1016/0040-4039(95)01886-M
(1995)Doi:10.1016/j.tet.2006.04.073
(2006)Doi:10.1021/ja00316a016
(1984)Doi:10.1134/S1068162016010040
(2016)Doi:10.1021/jp037008q
(2004)